Clinical mobility Target healthcare providers and clinics that treat pediatric mobility disorders, highlighting BIOMOTUM’s clinical validation and impact on gait training to drive adoption of wearable rehabilitation systems.

Home and clinic Position BIOMOTUM as a versatile solution for in-clinic, home, and community mobility therapy, offering remote monitoring and data-driven progression to appeal to providers looking for extended care models.

Pediatric focus Leverage a proven track record in improving mobility for children with cerebral palsy to pursue partnerships with pediatric hospitals, therapy networks, and caregiver programs seeking age-appropriate rehabilitation tech.

Small but scalable Emphasize the startup-to-growth narrative and potential for rapid product iteration, while recognizing their current team size; offer scalable enterprise partnerships and channel strategies with larger medical device distributors.

Data-driven value Sell the value of clinically validated outcomes and actionable activity data to therapists and administrators, enabling outcome tracking, reimbursement discussions, and evidence-based expansion of therapy programs.